ArticleNucleic acids research2025
Cyclic-di-GMP interferes with DNA-MucR-DNA bridging to derepress genes targeted by the xenogeneic silencer MucR.
Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Review
- Identifying Two New Ros/MucR Proteins: An Atypical Structure with a Divergent Function.Biomolecules · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The tradeoff between the benefits and costs of maintaining AT-rich accessory genes is vital in bacterial ecology and evolution. MucR is a conserved xenogeneic silencer for AT-rich accessory genes within α-proteobacteria, but its anti-silencing mechanisms remain unknown. By focusing on Sinorhizobium fredii, a facultative nitrogen-fixing microsymbiont of diverse legumes, this work reports that elevated c-di-GMP promotes the condition-dependent expression of various MucR1-targets, while downregulating the energy production and conversion pathway and reducing the NAD+/NADH ratio under both free-living and symbiotic conditions. Among the MucR1 targets responsive to c-di-GMP, an accessory module directing the biosynthesis of costly exopolysaccharides has been further studied. This anti-silencing process involves the sequential disruption of the DNA-MucR1-DNA bridging complex and the activation of a local transcriptional activator, CuxR. c-di-GMP directly binds to the C-terminal DNA-binding domain of MucR1, thereby facilitating intra- and inter-molecular interactions of MucR1. These interactions effectively alleviate the DNA-MucR-DNA bridging in the promoter region of target genes. This consequently enables the recruitment of the CuxR-c-di-GMP complex to the specific CuxR binding sites, which subsequently activates gene transcription. Collectively, accessory functions that are energetically costly and repressed by MucR1 can be harnessed by the ubiquitous messenger c-di-GMP through an integrated global-local signaling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.